首页|临床试验中细胞因子定量检测的专家共识(2024版)

临床试验中细胞因子定量检测的专家共识(2024版)

扫码查看
细胞因子是多种组织细胞中重要的信号分子,已成为临床试验中药效评估、安全性监测等不可或缺的检测指标.鉴于当前细胞因子定量检测在临床试验中面临多重问题与挑战的现状,中国药学会医药生物分析专业委员会组织多位行业专家进行了深入的研讨.本文系统阐述了各类细胞因子定量检测技术的原理及特点,对检测结果间的差异进行了全面的剖析;并结合法规文献与实践经验,就临床试验中细胞因子定量检测的一般原则达成了广泛共识,涵盖检测平台选择原则、检测方法验证要求、生物样品质量的影响因素等方面,旨在为此类研究的科学、规范开展提供实用性的参考.
Expert consensus on quantitative analysis of cytokines in clinical trials(2024 version)
Cytokines are important signaling molecules in various tissues and cells,and have become indispensable study content for pharmacodynamics evaluation and safety monitoring in clinical trials.In view of the current situation that quantitative analysis of cytokines in clinical trials is facing multiple problems and challenges,the Pharmaceutical Biological analysis Professional Committee of the Chinese Pharmaceutical Association organized experts to conduct in-depth discussions.This article elaborates on the characteristics of quantitative detection techniques systematically,and analyzes the differents between measurements.An expert consensus has been reached on the general principles of quantitative analysis of cytokines in clinical trials,covering the selection of analysis platforms,the requirements of bioanalytical method validation,and the influencing factors on biological samples,aiming to provide reference for the scientific and standardized conduct of such research.

cytokinequantitative analysisclinical trialexpert consensus

吴妮、孙云娟、胡建军、唐蕾、董菁、汤晓东、金凡、王洪允

展开 >

中国医学科学院北京协和医院临床药理研究中心,北京 100730

军科正源(北京)药物研究有限责任公司,北京 102206

徕博科医药研发(上海)有限公司,上海 201203

赛诺菲(中国)投资有限公司,北京 100022

恩凯塞药生物技术公司,上海 201318

展开 >

细胞因子 定量检测 临床试验 专家共识

2024

中国临床药理学杂志
中国药学会

中国临床药理学杂志

CSTPCD北大核心
影响因子:1.91
ISSN:1001-6821
年,卷(期):2024.40(21)